Ledger.Open graph →
SEC Form D · filed December 12, 2024

Transcode Therapeutics, Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

David J. Bohan · Boston, MAExec · DirectorMagda A. Marquet · Boston, MADirectorErik A. Manting · Boston, MADirectorThomas A. Fitzgerald · Boston, MAExec · DirectorPhilippe A. Calais · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗